Literature DB >> 28303562

Association between ACTN3 R577X Polymorphism and Trunk Flexibility in 2 Different Cohorts.

Naoki Kikuchi1, Hirofumi Zempo2, Noriyuki Fuku2, Haruka Murakami3, Mikako Sakamaki-Sunaga4, Takanobu Okamoto4, Koichi Nakazato4, Motohiko Miyachi3.   

Abstract

α-Actinin-3 (ACTN3) R577X polymorphism is associated with muscular strength and power. This study was performed to investigate the association between ACTN3 R577X polymorphisms and flexibility as another component of fitness in 2 cohorts. Cohort 1 consisted of 208 men and 568 women (ages 23-88), while Cohort 2 consisted of 529 men and 728 women (ages 23-87). All participants were recruited from the Tokyo metropolitan area and underwent a battery of tests to assess their grip strength and sit-and-reach flexibility. Genotyping results were analyzed for ACTN3 (rs1815739) polymorphism using the TaqMan approach. In Cohort 1, sit-and-reach in the RR genotype (35.3±0.7 cm) was significantly lower than those in the RX and XX genotypes (37.2±0.3 cm) even after adjusting for sex, age, and exercise habit as covariates (P<0.01). In Cohort 2, sit-and-reach tended to be lower in RR (38.1±0.6 cm) than in RX and XX (39.1±0.3 cm), but the differences were not significant (P=0.114). Analysis in pooled subjects indicated that RR was associated with significantly lower flexibility than RX and XX (P=0.009). The RR genotype of ACTN3 R577X in the general Japanese population showed lower flexibility compared to the RX and XX genotypes. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28303562     DOI: 10.1055/s-0042-118649

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  7 in total

Review 1.  More than a 'speed gene': ACTN3 R577X genotype, trainability, muscle damage, and the risk for injuries.

Authors:  Juan Del Coso; Danielle Hiam; Peter Houweling; Laura M Pérez; Nir Eynon; Alejandro Lucía
Journal:  Eur J Appl Physiol       Date:  2018-10-16       Impact factor: 3.078

2.  Greater Progression of Age-Related Aortic Stiffening in Adults with Poor Trunk Flexibility: A 5-Year Longitudinal Study.

Authors:  Yuko Gando; Haruka Murakami; Kenta Yamamoto; Ryoko Kawakami; Harumi Ohno; Susumu S Sawada; Nobuyuki Miyatake; Motohiko Miyachi
Journal:  Front Physiol       Date:  2017-06-30       Impact factor: 4.566

Review 3.  ACTN3: More than Just a Gene for Speed.

Authors:  Craig Pickering; John Kiely
Journal:  Front Physiol       Date:  2017-12-18       Impact factor: 4.566

4.  ACTN3 R577X Genotype and Exercise Phenotypes in Recreational Marathon Runners.

Authors:  Juan Del Coso; Victor Moreno; Jorge Gutiérrez-Hellín; Gabriel Baltazar-Martins; Carlos Ruíz-Moreno; Millán Aguilar-Navarro; Beatriz Lara; Alejandro Lucía
Journal:  Genes (Basel)       Date:  2019-05-29       Impact factor: 4.096

5.  The association of ACTN3 R577X polymorphism with sports specificity in Japanese elite athletes.

Authors:  Nobuhiko Akazawa; Nao Ohiwa; Kazuhiro Shimizu; Natsumi Suzuki; Hiroshi Kumagai; Noriyuki Fuku; Yasuhiro Suzuki
Journal:  Biol Sport       Date:  2021-11-10       Impact factor: 4.606

6.  Genetic profile of sports climbing athletes from three different ethnicities.

Authors:  Mika Saito; Michał Ginszt; Ekaterina A Semenova; Myosotis Massidda; Kinga Huminska-Lisowska; Monika Michałowska-Sawczyn; Hiroki Homma; Paweł Cięszczyk; Takanobu Okamoto; Andrey K Larin; Edward V Generozov; Piotr Majcher; Koichi Nakazato; Ildus I Ahmetov; Naoki Kikuchi
Journal:  Biol Sport       Date:  2021-11-10       Impact factor: 4.606

7.  Is COL1A1 Gene rs1107946 Polymorphism Associated with Sport Climbing Status and Flexibility?

Authors:  Mika Saito; Michał Ginszt; Ekaterina A Semenova; Myosotis Massidda; Kinga Huminska-Lisowska; Monika Michałowska-Sawczyn; Hiroki Homma; Paweł Cięszczyk; Takanobu Okamoto; Andrey K Larin; Edward V Generozov; Piotr Majcher; Koichi Nakazato; Ildus I Ahmetov; Naoki Kikuchi
Journal:  Genes (Basel)       Date:  2022-02-23       Impact factor: 4.141

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.